Trust CO Of Oklahoma Bristol Myers Squibb CO Transaction History

Trust CO Of Oklahoma

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $65 - $74	-1 Reduced 0.02%	4,840 $335,000
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.02%	4,841 $0
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $6 - $4,072	-53 Reduced 1.08%	4,840 $344,000
Q1 2022 May 25, 2022	SELL	$61.48 - $73.72 $6,086 - $7,298	-99 Reduced 1.98%	4,893 $357,000
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $61,674 - $71,898	-1,150 Reduced 18.72%	4,992 $311,000
Q3 2021 Oct 08, 2021	BUY	$59.17 - $69.31 $23,668 - $27,724	400 Added 6.97%	6,142 $363,000
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $60,645 - $68,208	1,022 Added 21.65%	5,742 $362,000
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $31,699 - $35,921	-549 Reduced 10.42%	4,720 $292,000
Q3 2020 Oct 08, 2020	SELL	$57.43 - $63.64 $259,181 - $287,207	-4,513 Reduced 46.14%	5,269 $317,000
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $177,990 - $258,661	-3,836 Reduced 28.17%	9,782 $545,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $670,141 - $874,139	13,618 New	13,618 $874,000
Q4 2018 Jan 23, 2019	SELL	$48.76 - $63.23 $161,249 - $209,101	-3,307 Closed	0 $0
Q3 2018 Oct 12, 2018	SELL	$55.19 - $62.25 $31,016 - $34,984	-562 Reduced 14.53%	3,307 $0
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $2,425 - $3,023	-48 Reduced 1.23%	3,869 $0
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $778 - $896	-13 Reduced 0.33%	3,917 $0
Q4 2017 Jan 11, 2018	BUY	$59.94 - $65.35 $235,564 - $256,825	3,930	3,930 $0

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Trust CO Of Oklahoma, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Oklahoma with notifications on news.